Full Archive

History repeats itself

Not sure how many of my readers remember the FreeStyle Navigator and its history but it’s worth reviewing. We thought of the Navigator and its history while looking over the results released by Embecta this morning. Embecta is best at making sharp objects that stick people, yet they continue to pursue projects outside of their competency. The latest and most talked about is their closed loop patch pump for Type...

A Step Closer

We won’t claim victory just yet but another prediction we made just became more of a possibility with Insulet acquiring patents from Bigfoot Biomedical. “Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, and Bigfoot Biomedical (Bigfoot), a leader in developing intelligent connected injection support systems, today announced Insulet has acquired assets related to Bigfoot’s pump-based automated insulin delivery (AID) technologies....

Fact Vs Fiction

Before we  begin feel free to share this post with anyone you like. Since President Biden mentioned capping the out-of-pocket cost of insulin in his State of the Union address there have been a plethora of articles on the subject. Many are like the one posted by Vox entitled Insulin is way too expensive. California has a solution: Make its own. Written by Dylan Scott. Let me state from the outset that...

It took a big bat

Back in the day Momma Kliff was fond of saying that sometimes you have hit people with a baseball bat before they pay attention. This is how I felt listening to the Dexcom earnings call as all of sudden it started to dawn on analysts that hey Dexcom really has a good thing going and it almost doesn’t matter what Abbott says. We say almost because there are still some...

Do the math

Later today Dexcom will report results which really should come with few surprises as back on January 9th during JPM the company issued preliminary unaudited results. Since then, the company has announced they are returning to the Superbowl with another Nick Jonas spot. A spot which is generating tons of free publicity for the G7 already a wildly anticipated product. Now we must admit other than the fact that Mr. Jonas...

Bringing out the heavy artillery

Many years way back in the day when BGM not CGM ruled the glucose monitoring universe I predicted that one day we would see TV commercials for glucose monitors. That same prediction noted that besides TV commercials BGM companies would start issuing coupons and other tactics employed by consumer products. The reason was simple while everyone was seeing a medical device, we saw BGM as a consumer device and therefore...

Is it even a fair fight?

When it comes to weight loss or perhaps, we should say sustained weight loss behavior change just doesn’t cut it. More often than not after losing all the weight the person goes back to their old behavior and regains the weight. Of course, there are exceptions to this but based on numerous studies this is more the norm. This is one reason we’ve never been a huge fan of any...